SGK1 and head and neck squamous cell carcinoma: Besides aiming on a reduction of dexamethasone use in solid cancers including HNSCC, research is needed respective to hormone receptor signaling and its impact on distant metastasis and blocking these pathways, e.g. by using inhibitors for MAST1 (22) or SGK1 (23).